Plain-English translation of NCT06888193 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study is measuring how much —a medication used to treat psoriasis, psoriatic arthritis, and related inflammatory conditions—passes into breast milk. Researchers want to understand whether mothers taking this medication can safely breastfeed. The information will help doctors and mothers make informed decisions about treatment and feeding choices.
Mothers with psoriasis and related conditions want to keep taking their medication to stay healthy, but they also want to breastfeed safely. Currently, there isn't enough information about how much of this medication enters breast milk. This study will help doctors give better guidance to mothers facing this important choice.
You likely qualify if…
You likely don't qualify if…
You would continue taking your medication exactly as your doctor prescribes—nothing changes about your treatment. The study simply involves collecting samples of your breast milk at specific times so researchers can measure medication levels. You would provide these samples while breastfeeding normally, and your baby's care would not be affected. The entire study takes place over a few weeks of milk collection.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
United States